News Page for: DMATek (graph)

Add some news
     

 

Item
Date
Source & Article
1
12th Aug 2000
 FT: Interim Results - half year to june. Pre-Tax Profit $1.55m (0.375). No divi.
2
 27 Feb 2001 DMATEK LTD Final results for the year ending 31st December 2000 Tel Aviv, ISRAEL (26 October, 2000) - Dmatek Ltd., ('Dmatek' or 'the Company') announces an extraordinary general meeting of the Company's shareholders for 10:00 on November 16, 2000 at the Company's registered offices: 2 Habarzel St., Tel Aviv. Dmatek Ltd., ("Dmatek or the "Company") the London listed provider of leading electronic monitoring technologies, today announces its final results for the year ending 31st December 2000. The main highlights of today's announcement are: Highlights of the Period: Revenues for the year increased 49% to $15.1 million (1999 - $10.16 million) Profits attributable to shareholders increased 28% to $2.25 million (1999 - $1.76 million) R&D and marketing efforts increased 70% compared with 1999 Two new platforms, including a first integrated cellular system launched Nine pilot systems, including two commercial Alzheimer's trials, running or ready to start Four state accounts won in the US, three key European awards for initial trials US$10 million raised from institutional investors. Listing promoted from AIM to the Official List and included in the techMARK index Commenting on the results Yoav Reisman, CEO, said: "This year's acheivements put us in a strong position to expand our existing business, break into new markets and enhance our technological capabilities with new developments. We intend to further pursue our strategy -stressing R&D activities and focused marketing efforts of both our subsidiaries in their respective markets. We will strive to ensure Dmatek's leading position as a source for advanced electronic monitoring technologies and replicate our commercial success."
3
3rd Mar 2001
 FT Prelims: Pre-tax profit £2.22m (£1.69m); EPS 11p (1p); divi - (-)
.
.
  
.
.
 .
.
.
 .
.
.
 .
.
.
 .